Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China flag China · Delayed Price · Currency is CNY
37.97
-0.79 (-2.04%)
Nov 13, 2026, 3:00 PM CST

SHA:688580 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
159.89138.07101.97136.2693.83177.81
Depreciation & Amortization
27.2727.2721.9820.1417.1411.08
Other Amortization
2.022.021.431.841.680.38
Loss (Gain) From Sale of Assets
00-00--
Asset Writedown & Restructuring Costs
--0.010.010.010.01
Loss (Gain) From Sale of Investments
-17.37-17.37-13.76-9.62-16.01-20.56
Provision & Write-off of Bad Debts
0.840.841.442.270.680.89
Other Operating Activities
-44.131.731.181.240.33-0.09
Change in Accounts Receivable
-35.6-35.67.77-21.777.32-13.14
Change in Inventory
-3.9-3.91.15-5.081.816.67
Change in Accounts Payable
61.7161.71-9.17-3.48-20.13-18.96
Change in Other Net Operating Assets
2.482.483.4719.65-2.8321.37
Operating Cash Flow
152.7176.74118.29134.286.17157.37
Operating Cash Flow Growth
-5.11%49.42%-11.86%55.74%-45.24%30.31%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-132.84-118.12-113.08-133.48-95.61-87.34
Sale of Property, Plant & Equipment
108.1841.650.020--
Cash Acquisitions
-29.65-29.65--20.11-34.19-
Investment in Securities
-149.96-49.96--23--
Other Investing Activities
10.112.5812.2412.4825.0110.56
Investing Cash Flow
-194.17-143.49-100.82-164.11-104.8-76.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.88-1.55-1.35-14.87-1.35
Lease Payments
-0.88-0.88-1.55-1.35-14.87-1.35
Net Debt Issued (Repaid)
-0.88-0.88-1.55-1.35-14.87-1.35
Issuance of Common Stock
--13.32-10.79-
Repurchase of Common Stock
---13.64-11.58-2.02-
Common Dividends Paid
-102.56-76.57-102.2-51.04-88.91-71.83
Dividends Paid
-102.56-76.57-102.2-51.04-88.91-71.83
Other Financing Activities
0.3-----7.81
Financing Cash Flow
-103.13-77.45-104.07-63.96-95.01-80.99

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.25-0.040---
Net Cash Flow
-144.85-44.24-86.59-93.87-113.64-0.41

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
19.8658.635.210.72-9.4570.02
Free Cash Flow Growth
-65.43%1024.89%627.46%---35.82%
Free Cash Flow Margin
4.30%12.67%1.30%0.15%-2.94%16.28%
Free Cash Flow Per Share
0.210.610.060.01-0.100.73
Levered Free Cash Flow
-91.7621.738.41-26.08-15.43-4.02
Unlevered Free Cash Flow
-91.622.559.23-25.26-15.22-3.91
Free Cash Flow After Leases
18.9857.753.66-0.63-24.3268.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
44.9735.6844.5241.8240.1250.52
Change in Working Capital
24.1724.174.05-17.94-11.5-12.16